The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins (Q41991038)

14 October 2017

The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins (English)

1 reference

14 October 2017

1 reference

8

Maria Grazia Bendini

1 reference

14 October 2017

Massimo Leggio

1

1 reference

14 October 2017

Mario Lombardi

2

1 reference

14 October 2017

Elisa Caldarone

3

1 reference

14 October 2017

Paolo Severi

4

1 reference

14 October 2017

Stefania D'Emidio

5

1 reference

14 October 2017

Massimo Armeni

6

1 reference

14 October 2017

Veronica Bravi

7

1 reference

14 October 2017

Andrea Mazza

9

1 reference

14 October 2017

5 October 2017

1 reference

14 October 2017

Hypertension Research

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2017.75

14 October 2017

0 references

cites work

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Overview of epidemiology and contribution of obesity to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Estimating the risk of cardiovascular disease using an obese-years metric

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

UK health performance: findings of the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Hypertension management in England: a serial cross-sectional study from 1994 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Variations in blood pressure and lipid goal attainment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Relations of body weight status in early adulthood and weight changes until middle age with hypertension in the Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A global view on the development of non communicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Tackling the global NCD crisis: innovations in law and governance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Facing the noncommunicable disease (NCD) global epidemic--the battle of prevention starts in utero--the FIGO challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevalence of Overweight and Obesity in the United States, 2007-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FHR.2017.75

21 January 2018

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Mechanisms of obesity-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Perspective: Obesity is not a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body-mass index and mortality in Korean men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body weight and mortality among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Association between body-mass index and risk of death in more than 1 million Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The metabolically healthy but obese individual presents a favorable inflammation profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body fat distribution and risk of cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Relation of body fat distribution to metabolic complications of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Pathophysiology of hypertension in obese children: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Adiponectin and cardiovascular disease: response to therapeutic interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Modulation of adiponectin as a potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Leptin and cardiovascular disease: response to therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Receptor-mediated regional sympathetic nerve activation by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Relation of obesity and diet to sympathetic nervous system activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body fat and sympathetic nerve activity in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Kidney disease in the obese patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body mass index and angiotensin-dependent control of the renal circulation in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity, sleep apnea, aldosterone, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Sleep as a mediator of the relationship between socioeconomic status and health: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Sympathetic nerve activity in obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity, Sleep Apnea, and Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Fetal programming of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Elevated sympathetic nerve activity: the link between low birth size and adult-onset metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and overweight associated with increased carotid diameter and decreased arterial function in young otherwise healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The treatment of hypertension in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Metabolically healthy but obese women: effect of an energy-restricted diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Metabolically-healthy obesity and coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A detailed cardiovascular characterization of obesity without the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Metabolically healthy obesity: different prevalences using different criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity phenotype and incident hypertension: a prospective community-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Is it finally time to dispel the concept of metabolically-healthy obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and cardiovascular disease: weight loss is not the only target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity paradox in patients with hypertension and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Healthy obese versus unhealthy lean: the obesity paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of sleep debt on metabolic and endocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Sleepless in America: a pathway to obesity and the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and metabolic syndrome in circadian Clock mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Insufficient Sleep Undermines Dietary Efforts to Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The pathophysiology of heart failure with preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Glucose and the risk of hypertension in first-degree relatives of patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Secular trends of the impact of overweight and obesity on hypertension in Japan, 1980-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Association of body mass index and left ventricular mass index with abnormally low and high ankle-brachial indices in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: a 6-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Pulse wave velocity in elastic and muscular arteries: tracking stability and association with anthropometric and hemodynamic measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Childhood adiposity, adult adiposity, and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Tracking of obesity-related behaviours from childhood to adulthood: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Perinatal and childhood origins of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Longitudinal modelling of body mass index from birth to 14 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A controlled evaluation of a fitness and nutrition intervention program on cardiovascular health in 10- to 12-year-old children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A controlled trial of health promotion programs in 11-year-olds using physical activity "enrichment" for higher risk children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevention of Overweight in Infancy (POI.nz) study: a randomised controlled trial of sleep, food and activity interventions for preventing overweight from birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Cardiovascular health promotion for children: a model for a Parish (County)-wide program (implementation and preliminary results).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A randomised controlled trial for overweight and obese parents to prevent childhood obesity--Early STOPP (STockholm Obesity Prevention Program).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Assessing the efficacy of the Healthy Eating and Lifestyle Programme (HELP) compared with enhanced standard care of the obese adolescent in the community: study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

EPODE approach for childhood obesity prevention: methods, progress and international development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Global nutrition transition and the pandemic of obesity in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Closing the energy gap to prevent weight gain in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Translational research: bridging the gap between long-term weight loss maintenance research and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Prevalence of obesity among US preschool children in different racial and ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of exercise training on systo-diastolic ventricular dysfunction in patients with hypertension: an echocardiographic study with tissue velocity and strain imaging evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of long-term lifestyle programmes on weight loss and cardiovascular risk factors in overweight/obese participants: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Lifestyle intervention has a beneficial effect on eating behavior and long-term weight loss in obese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A systematic review of weight loss, physical activity and dietary interventions involving African American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Diet, exercise or diet with exercise: comparing the effectiveness of treatment options for weight-loss and changes in fitness for adults (18-65 years old) who are overfat, or obese; systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The treatment of obesity in cardiac rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A lifestyle program of exercise and weight loss is effective in preventing and treating type 2 diabetes mellitus: Why are programs not more available?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

State of the evidence regarding behavior change theories and strategies in nutrition counseling to facilitate health and food behavior change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Reducing weight in an internal medicine outpatient clinic using a lifestyle medicine approach: A proof of concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Exercise improves cardiac autonomic function in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Influence of Physical Activity on Hypertension and Cardiac Structure and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The role of exercise and physical activity in weight loss and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Long-term weight loss from lifestyle intervention benefits blood pressure?: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Lifestyle and pharmacological approaches to weight loss: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

ASH position paper: Dietary approaches to lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Vegetarian diet components, protein and blood pressure: which nutrients are important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Suboptimal nutritional intake for hypertension control in 4 ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Does physical activity prevent weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The effect of physical activity on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Sedentary behaviors and health outcomes among adults: a systematic review of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Alcohol Abuse and Cardiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Alcohol is bad for blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Alcohol consumption and body weight: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

What is the most effective way to maintain weight loss in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Cognitive and behavioral approaches in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Associations of internet website use with weight change in a long-term weight loss maintenance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Cardiovascular, renal and overall health outcomes after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effect of weight loss on pulse wave velocity: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Feasibility and Impact of a Combined Supervised Exercise and Nutritional-Behavioral Intervention following Bariatric Surgery: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Weight loss strategies for treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

A role for exercise after bariatric surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The Healthy Lifestyle Team is Central to the Success of Accountable Care Organizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity medications: what does the future look like?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Clinical impact of left ventricular hypertrophy and implications for regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Impact of echocardiographic left ventricular geometry on clinical prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Effect of Body Mass Index Changes Between Ages 5 and 14 on Blood Pressure at Age 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Visceral Adipose Tissue Accumulation, Cardiorespiratory Fitness, and Features of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Dietary approaches to the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Stemming the global tsunami of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

Fetal and Childhood Growth and Hypertension in Adult Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

The relation of adiposity to blood pressure and development of hypertension. The Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Obesity and hypertension--the issue is more complex than we thought

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Sympathetic neural activation in visceral obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Sympathetic activation in obese normotensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Decreased plasma adiponectin concentration in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Fetal hyperinsulinism in offspring of diabetic mothers. Association with the subsequent development of childhood obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Obesity phenotype and cardiovascular changes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Obesity, heart disease, and favorable prognosis--truth or paradox?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Revisiting the obesity paradox in heart failure: new insights?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Serum uric acid is associated with microalbuminuria in prehypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Effect of metabolic syndrome components and their clustering on carotid atherosclerosis in a sample of the general Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Interventions for preventing obesity in children

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

One year follow-up of overweight and obese hypertensive adults following intensive lifestyle therapy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Exercise is good for your blood pressure: effects of endurance training and resistance training

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Exercise and weight control in sedentary overweight men: effects on clinic and ambulatory blood pressure.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2017.75

7 January 2021

Exercise for overweight or obesity

1 reference

12 December 2020

Long-term effects of weight-reducing diets in people with hypertension

1 reference

12 December 2020

Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

1 reference

12 December 2020

Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women

1 reference

12 December 2020

Insulin and renal sodium handling: clinical implications

1 reference

12 December 2020

Regulation of arterial pressure: role of pressure natriuresis and diuresis

1 reference

12 December 2020

The russert impact: a golden opportunity to promote primary coronary prevention.

1 reference

12 December 2020

Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006.

1 reference

12 December 2020

Behavioral lifestyle intervention in the treatment of obesity

1 reference

12 December 2020

Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors.

1 reference

12 December 2020

The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group

1 reference

12 December 2020

Clustering of cardiovascular risk factors in Australian adolescents: association with dietary excesses and deficiencies.

1 reference

12 December 2020

Surgery for weight loss in adults

1 reference

12 December 2020

Identifiers

DOI

10.1038/HR.2017.75

1 reference

Dimensions Publication ID

14 October 2017

0 references

1 reference